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Introduction 
Severe persistent pain following back surgery is often 
referred to as "Failed Back Surgery Syndrome" (FBSS)!. 
The cause of the pain is multi-factorial. Inadequate 
surgery with failure to recognize or treat lateral stenosis 
of the lumbar spine with resultant nerve irritation is a 
common cause. Other causes are recurrent or persistent 
disc herniation, epidural scarring, lumbosacral adhesive 
arachnoiditis and vertebral instability!,2. Multiple 
surgery is usually attempted in an effort to alleviate pain 
and suffering. Pain is often described as severe pain in 
the back with radiation down the back of one or both 
legs. It is usually neuropathic in origin due to nerve 
entrapment in scar tissue. Inadequate pain relief hinders 
exercise and reduces mobility. As a result, patients get 
into a vicious cycle where chronic pain becomes a central 
focus in their lives. They become depressed and their 
social and family life suffers. 
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Conservative multimodal management includes patient 
education, physiotherapy with back strengthening 
exercises, transcutaneous electrical nerve stimulation 
(TENS), and the judicious use of analgesic drugs in an 
effort to break the vicious cycle of pain and muscle 
spasm. These maneuvers can improve mobility and may 
allow patients to have a better qualiry of lifel . Epidural 
steroids can be administered in an effort to reduce 
epidural scarring, which is often the main cause for 
nerve entrapment and pain4 • Spinal cord stimulation, a 
technique which is increasingly being used for FBSS, 
can be offered when the above measures fai14". We 
present two patients who have benefited from 
implantation of spinal cord stimulators. 
Case 1 
A 44-year old, single Malay woman (RH) was referred to 
the Pain Control Clinic in October 1996 with a four 
year history of severe low back pain with radiation down 
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the legs. She gave a history of an episode of acute back 
pain in 1992, which was initially treated conservatively, 
but had had two back surgeries since then. A 
laminectomy for a herniated intervertebral disc at L 3-4 
level and spinal fusion for persistent pain following the 
laminectomy. At the time of presentation she was in a 
great deal of discomfort despite controlled release 
morphine sulfate 30mg twice a day and carbamazepine 
200mg three times a day. She had been off work for 
more than a year and could barely manage everyday 
activities. A MRI showed extensive epidural scarring 
from previous surgeries. Conservative management with 
physiotherapy, transcutaneous electrical nerve 
stimulation, addition of gabapentin to the opioid 
medication and a trial of epidural steroid injections over 
the ensuing two months failed to provide any significant 
relief. She was then offered a trial of a spinal cord 
stimulator. 
With the patient in a prone position, under local 
anaesthesia and X-ray control, a single Pisces-Quad 
lead- Model 3487 A (Medtronic Inc. Minneapolis, MN, 
USA) was inserted percutaneously into the epidural 
space via the lumbar 1 - 2 interspace and threaded up to 
the lower border of the body of T8 vertebra. (Fig. 1) A 
fig, 1: 
510 
X-ray (PA view) of the thoracic: spine 
from 18 . T1 0 showing the midline 
position of the lead with its four 
electrodes 
temporary screener kit was used to adjust the position of 
the lead in the epidural space so that the patient felt 
paresthesia (tingling sensation) over the painful areas of 
her back and legs. The lead was attached to a temporary 
extension, which was exteriorized and connected to a 
temporary screening stimulator. She was sent home the 
following day and advised to continue with stimulation 
for 10 - 20 minutes every three to four hours while 
maintaining a detailed record of activities in association 
with pain relief. She obtained excellent pain relief over 
the ensuing week with marked reduction in analgesic 
medications and we decided to implant a permanent 
SCS system. Under general anaesthesia, the temporary 
screener kit was replaced with a permanent Xtrel 
Receiver - Model 3470 (Medtronic) which was 
implanted in a subcutaneous pouch in the anterior 
abdominal wall and connected to the original epidural 
lead with a subcutaneously placed extension cable. 
She continued to obtain excellent relief over the next 
four weeks, using an X-trel External Transmitter and 
antenna (Model 3425) over the implanted receiver for 
stimulation and for the first time in four years was able 
to move around without discomfort. Four weeks after 
the initial implantation, she suffered a setback when she 
came back to the hospital with severe postural headache. 
Neurological examination including CT scan of brain 
did not reveal any abnormality and she had no signs of 
any infection. A lumbar puncture done to rule out 
cryptococcal infection revealed low CSF pressure. A 
presumptive diagnosis of late post-dural puncture 
headache was made and she was treated with an epidural 
blood patch. She improved dramatically after the blood 
patch and was able to get back to light duties about ten 
weeks after the initial implantation. She remained well 
over the next eight months and had sufficient pain relief 
to be able to travel to Mecca for the Umrah. Pain 
recurred following a motor vehicle accident at the end of 
October 97. X-rays showed that the epidural lead had 
shifted up by 0.5cm. The stimulation parameters and 
electrode combinations were readjusted to cover the 
painful areas and pain relief was regained. Eighteen 
months after the initial implantation, the patient is 
well, is continuing to obtain sufficient pain relief with 
the stimulator to allow her to carry out her normal 
activities at home. Her medication intake is down to 
oral Tramadol 50mg, twice a day. 
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A 32-year-old Chinese woman (YSC) was referred to the 
Pain Control Clinic in December 1995 with complaints 
of severe back pain radiating down both legs. She had 
had a lumbar laminectomy 18 months prior to her 
referral, for a herniated intervertebral disc. She was 
unable to undertake her duties as a lecturer and had been 
off work of a year. Clinical examination and MRI scan, 
which showed epidural scarring, was consistent with the 
diagnosis of 'failed back surgery syndrome'. 
Conservative management included patient education, 
epidural steroid injections, physiotherapy and a trial of 
transcutaneous electrical nerve stimulation. She 
obtained about 20 - 30% pain relief with these measures 
and was sufficiently confident to go back to teaching 
part time at the University. Analgesic medication 
consisted of tramadol, as the patient was allergic to a 
variety of non-steroidal-anti-inflammatory drugs. A trial 
of gabapentin produced marked rash and was promptly 
discontinued. She was managed conservatively over the 
next eighteen months but continued to have episodes of 
severe leg pain. She was becoming depressed and hardly 
went out socially. In view of the success we had with the 
previous patient she was offered spinal cord stimulation. 
A single Pisces Quad lead Model 3487 A (Medtronic 
Inc., Minneapolis, MN, USA) was inserted, in the same 
manner as described in Case 1, at the Lumbar 1 - 2 
interspace and threaded up to T8. Paresthesia was 
obtained over one side of the back and down both legs 
at 4.5V. She was sent home for a trial stimulation period 
of a week. She returned to the hospital prematurely with 
sharp pain in the interscapular region coinciding with 
the onset of stimulation. Extensive changes to 
stimulation parameters, such as rate, pulse width and 
electrode combinations as well as an attempt to readjust 
the lead under local anaesthesia failed to solve the 
problem and the lead was removed. 
The procedure was repeated four weeks later using two 
leads in an attempt to provide wider coverage The first 
lead, a Pisces Quad 3487 A (Medtronic) was inserted 
into the epidural space through the T12 - 11 interspace 
and another similar lead was inserted via a lower 
interspace, at Ll - L2. The leads were threaded up to the 
Med J Malaysia Vol 54 No 4 Dec 1999 
SPINAL CORD STIMULATION 
Fig. 2: X"ray (PI. view) of the theracic spine 
T1 • 1'10 shews the position of the 
two leads in the midline ef the 
epidural space 
bodies ofT8 and T9 vertebrae (Fig. 2) and the positions 
adjusted to obtain J?aresthesia over the whole of the back 
and down the back of both legs including the feet. The 
two lead extensions were exteriorized and connected to 
the temporary screening kit. After a successful trial 
period of two weeks, a Mattrix Implantable Receiver 
Model 3272 (Medtronic Inc) was implanted under 
general anaesthesia. It was placed in a subcutaneous 
pouch in the anterior abdominal wall and the dual 
extensions were connected to the two epidural leads 
using a subcutaneous tunnel. The Mattrix External 
Tranmitter Model 3210 with antenna was used over the 
implanted receiver to obtain spinal cord stimulation. At 
follow up, a month later, the patient continued to obtain 
excellent pain relief with stimulation and was able to 
stop all analgesic medications. Fifteen to twenty 
minutes of SCS provided three to four hours of total pain 
relief. In addition, she was ready to undertake a part 
time further education course as well as continue with 




Spinal cord stimulation (SCS) for control of pain was 
introduced by Shealy et al in 19676• Low voltage electrical 
stimulation is applied to the spinal cord to create a 
current field, which activates neurons in the dorsal 
columns. The analgesia produced by SCS is based on the 
widely accepted Gate Control Hypothesis, although the 
neuroanatomical and physiological mechanisms which 
make it work are poorly understood7 • SCS was popular 
soon after its introduction, but interest waned due to poor 
results, mainly due to improper patient selection. Recent 
advances in hardware technology, methods of 
implantation and stricter criteria for patient selection 
have led to a resurgence of the techniques. 
North et al demonstrated that superimposing the 
paraesthesia, created by electrical stimulation of the 
spinal cord, over the patient's area of pain is a necessary 
condition for pain reliefl'. Intra-operative testing, with 
the patient's cooperation, is therefore an essential tool 
for optimum placement of the lead. Trial stimulation in 
the patient's own home is also important, as it allows the 
patient to decide whether stimulation is effective in 
reducing pain during ordinary activities of daily living. 
If the trial period does not result in at least 50% 
reduction of pain, it is deemed to be a failure and the 
lead is removed. The permanent receiver is therefore 
only implanted in those patients who have responded 
positively to the trial stimulation. This sequence can 
reduce the cost of a trial stimulation by half with 
considerable cost savings. We repeated the trial in our 
second case, as the patient did not have an opportunity 
to really test the device due to severe interscapular pain 
with stimulation. The pain could have been due to the 
close proximity of the electrode to a nerve root. 
Failed Back Surgery Syndrome (FBSS) is one of the 
commonest indications for SCS. In a 5-year follow up 
study of 50 patients with FBSS who had SCS implanted, 
North et al recorded a successful outcome (at least 50% 
sustained pain relief) in 53% of patients at 2.2 years and 
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47% of patients at 5.0 yearss. Ten of 40 patients who 
were disabled preoperatively returned to work with 
marked improvement in activity. Most patients had also 
reduced or eliminated analgesic intake. Both our 
patients had marked improvement in their functional 
status and the second patient was able to stop all 
analgesics. SCS has also been shown to have a 
significantly higher success rate in females than males, 
and in radicular rather than axial pains. Turner et al 
reviewed all literature concerning the use of SCS for 
back pain and found that 50 - 60% of patients had a 
successful outcome with the procedure. Forty two 
percent of them had complications, but most of these 
were minor9. Complications that have been reported are 
CSF leak!O, infection at the site of implantation, 
breakage of leads and lead migration which may 
necessitate removal or readjustment of leads. 
Better outcomes seen in recent studies could be due to 
more stringent criteria being applied for SCS 
implantation. Pain is a complex mix of physical and 
psychosocial factors and therefore psychological 
assessments are usually recommended prior to any 
interventional therapy. Psychological tests cannot 
predict treatment outcome but have been found to assist 
in patient selection i.e. to exclude patients with risk 
factors such as a drug addiction problem, a serious mood 
disorder or borderline personality disorderll • SCS has 
also been used in the successful management of other 
types of neuropathic pain syndromes such as complex 
regional pain syndrome - Type I (reflex sympathetic 
dystrophy) and in patients with peripheral vascular 
insufficiency' . 
Conclusion 
Chronic pain of FBSS is difficult to treat. When 
conservative modalities fail, SCS may be an option is 
selected cases, particularly when pain is largely 
neuropathic in origin. 
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